PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Calcium folinate - Prevention of methotrexate induced adverse effects
PAD Profile : Calcium folinate - Prevention of methotrexate induced adverse effects
Keywords :
Folinic acid
Brand Names Include :
Refolinon
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
26 September 2007
Not Set
This is conisdered as a red drug and as such is not suitable for prescribing in primary care - refer back to the Acute Trust
Associated BNF Codes
08. Malignant Disease and Immunosuppression
08.01.00. Drugs for cytotoxic-induced side-effects